7th Intern Conf on AD and Related Disorders in the Middle East

项目摘要 阿尔茨海默病是一个主要的健康问题，也是美洲和欧洲痴呆症的主要原因。 在中东，对痴呆症的研究很少。这是一个重要的问题，因为 包括中东在内的世界人口逐渐老龄化。例如， 埃及60岁及以上的人口预计将从2000年到2030年增加316%。此外，Public 中东地区对痴呆症的认识很低，在许多情况下，痴呆症患者不接受医疗服务。 关注这项建议的目的是争取对第七次国际会议的支持， 阿尔茨海默氏病及相关疾病在中东。本次会议的目标是重点 注意中东的老年人神经退行性疾病，特别是阿尔茨海默病， 提高科学、医学和社会对这些疾病的认识，并加强 阿拉伯人和犹太人的医疗和科学人员之间，以及中东工人和他们的同行之间 在其他国家，尤其是美国。预计这次会议将导致增加对下列问题的研究： 中东地区的痴呆症具有独特的研究价值，包括高发病率 血缘和吸烟，相对同质的人群，高脂肪饮食。其中两名组织者是 来自中东的背景，并完全熟悉该地区的文化传统，并沿着 与这些会议的过去组织者，建立了持续的合作关系， 中东地区目标受众为临床医生、科学家、护士、社会工作者、政府代表 和其他机构，制药和其他生物技术公司将出席会议， 2016年11月4日至6日，阿拉伯联合酋长国阿布扎比。与会者将来自中东的大多数 巴林、埃及、伊朗、以色列、约旦、黎巴嫩、巴勒斯坦领土、卡塔尔、沙特阿拉伯、 叙利亚、突尼斯、土耳其、阿拉伯联合酋长国和约旦河西岸，将包括来自欧洲、北 美国和世界其他地区。主题包括临床和基础科学方面的 痴呆症，诊断，历史，管理，治疗和伦理，考虑到独特的文化 阿拉伯人和犹太人的传统。主办方已成功举办了六届 根据过去的经验，期待第七次会议取得更大的成功。 第七届会议将在以往会议成功的基础上， 他说，这是第一次在中东的心脏地带举行会议。

Project Summary Alzheimer’s disease is a major health problem and the leading cause of dementia in the Americas and Europe. There has been little work done on dementia in the Middle East. This is an important issue because of the progressive aging of the populations of the world, including the Middle East. For example, the size of the population of Egyptians 60 years and older is expected to increase by 316% from 2000 to 2030. Also, public awareness of dementia in the Middle East is low, and in many cases demented patients do not receive medical attention. The goal of this proposal is to obtain support for the Seventh International Conference on Alzheimer’s Disease and Related Disorders in the Middle East. The objectives of this conference are to focus attention on neurodegenerative disorders of the aged, particularly Alzheimer’s disease, in the Middle East, to raise scientific, medical and social awareness of these disorders, and to enhance communication between Arab and Jewish medical and scientific personnel, and between Middle Eastern workers and their counterparts in other countries, particularly the USA. It is anticipated that the meeting will lead to increased studies of dementia in the Middle East, a region with unique features valuable for research, including a high rate of consanguinity and smoking, relatively homogenous populations, and high fat diet. Two of the organizers are from Middle Eastern background and are thoroughly familiar with the cultural traditions of the region, and along with the past organizer of these conferences, have built continuing collaborative relationships with workers in the Middle East. A target audience of clinicians, scientists, nurses, social workers, government representatives and other agencies, pharmaceutical and other biotechnology companies will attend the meeting to be held in Abu Dhabi, United Arab Emirates, November 4-6, 2016. Attendees will be from the majority of Middle Eastern countries including Bahrain, Egypt, Iran, Israel, Jordan, Lebanon, Palestinian territories, Qatar, Saudi Arabia, Syria, Tunisia, Turkey, United Arab Emirates and the West Bank and will include workers from Europe, North America and other parts of the world. Topics to be covered include clinical and basic science aspects of dementia, diagnoses, history, management, treatment, and ethics, with consideration of the unique cultural traditions of Arab and Jewish populations. The organizers have successfully convened six editions of this conference in the past, and based on past experience expect an even more successful seventh conference. The seventh conference will build on the success of the past conferences, and will feature a number of new directions, including holding the conference, for the first time, in the heart of the Middle East.